Discovery & Preclinical
Set a clear product strategy, define a credible clinical and regulatory path, select the right asset and get ready for first-in-human trials with confidence
Oncology drug development is a demanding, complicated and highly competitive area. While there has never been as much opportunity and promise for patients, the challenges to achieve market success are ever increasing.
At tranScrip we bring many years of high-end experience in designing and delivering oncology programmes, including targeted treatments, immunotherapies, vaccines, cell-based products and novel cytotoxics.
We are able to help our clients seize opportunities, address challenges and succeed in their drug development or lifecycle management goals by adapting and adopting novel approaches and regulatory pathways.
We provide strategic expertise, therapeutic experience and operational excellence across the entire product lifecycle.
Set a clear product strategy, define a credible clinical and regulatory path, select the right asset and get ready for first-in-human trials with confidence
Implement first-in-human trials, interpreting emerging data and adapting plans as needed. Ensure robust decisions, including clear proof-of-concept
Design medically-endorsed pivotal programs that stand up to global regulatory and commercial scrutiny. Navigate issues in implementation
Interpret data, assess benefit/risk and secure regulatory approvals, successfully bring your medicine to market. Ensure strong lifecycle management
Director Regulatory Affairs
Daiichi Sankyo Europe GmbH
Get in touch to see how our senior cross-functional experts can help you reduce risk, protect value, and move forward with confidence.